These results show that re-expression of miR-101 significantly suppresses breast cell viability, while down-regulation of miR-101 evidently promotes breast cell proliferation in not only ER alpha-positive but also ER alpha-negative breast cancer cells and non-malignant mammary gland epithelial cells. The gene discussed is ESR1; the disease is breast carcinoma.